Market Place
Sourcing Support
Sun Pharma To Invest Up To $15M In Pharmazz
21 Aug 2024 //
GLOBENEWSWIRE
A Special Protocol Assessment Agreement Reached with FDA for Ph 3 of Sovateltide
02 Oct 2023 //
GLOBENEWSWIRE
Pharmazz Announces US FDA Clearance for a PhIII Clinical Trial of Sovateltide
13 Feb 2023 //
PR NEWSWIRE
Clinical PIII Trial Results Demonstrating Sovateltide`s Efficacy
10 Feb 2023 //
PR NEWSWIRE
Pharmazz Presents Results of PIII Trial Demonstrating Sovateltide’s Efficacy
31 Oct 2022 //
GLOBENEWSWIRE
Pharmazz announces Indian (CDSCO) Clearance of IND to a Phase 2 sovateltide
29 Aug 2022 //
GLOBENEWSWIRE
Pharmazz Completes Enrollment of Phase III Trial Evaluating Sovateltide
17 Feb 2022 //
GLOBENEWSWIRE
Pharmazz submits IND to CDSCO for Phase II trial of sovateltide (PMZ-1620)
03 Feb 2022 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.